Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 40 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.
根據最新的財務報表(Form-10K),Park Ha Biological Technology Co Ltd 的總資產為 $0,淨損失為 $0
BYAH 的關鍵財務比率是什麼?
Park Ha Biological Technology Co Ltd 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Park Ha Biological Technology Co Ltd 的收入按細分市場或地理位置如何劃分?
Park Ha Biological Technology Co Ltd 最大收入來源為 Franchise Fees,在最近的收益報告中收入為 1,510,809。就地區而言,China 是 Park Ha Biological Technology Co Ltd 的主要市場,收入為 2,524,843。
Park Ha Biological Technology Co Ltd 是否盈利?
無,根據最新的財務報表,Park Ha Biological Technology Co Ltd 的淨損失為 $0